BioNeutra Global Corporation announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced sales was CAD 9.022 million compared to CAD 12.193 million a year ago. Net loss was CAD 4.660 million compared to net income of CAD 604,339 a year ago. Basic loss per share was CAD 0.1 compared to basic earnings per share of CAD 0.01 a year ago. For the half year, sales was CAD 17.653 million compared to CAD 22.046 million a year ago. Net loss was CAD 5.791 million compared to net income of CAD 2.229 million a year ago. Basic loss per share was CAD 0.13 compared to basic earnings per share of CAD 0.05 a year ago.